Physician profile
Nathan Lipsett
NPI 1487628509
$6,266.84
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,865 · 2020: $1,604 · 2021: $1,430 · 2022: $1,304 · 2023: $63.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $63.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $63.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,716.19 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $1,180.96 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $942.08 | 2019-2022 | |
| Mylan Specialty L.P. | $459.00 | 2019-2022 | |
| Genzyme Corporation | $213.68 | 2019-2022 | |
| Grifols USA, LLC | $190.91 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $159.27 | 2019-2022 | |
| United Therapeutics Corporation | $154.04 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $147.44 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $129.53 | 2019-2021 | |
| Amgen INC. | $111.62 | 2022 | |
| Insmed, INC. | $86.80 | 2019-2022 | |
| Genentech USA, INC. | $83.38 | 2019-2022 | |
| Circassia INC. | $83.17 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $77.38 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $68.64 | 2020-2023 | |
| Baxter Healthcare | $65.89 | 2022 | |
| Kaleo, INC. | $47.36 | 2020-2021 | |
| Shire North American Group INC | $41.94 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.96 | 2020-2022 | |
| Optinose US, INC. | $34.20 | 2020 | |
| Pfizer INC. | $31.12 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $30.39 | 2021-2022 | |
| Inari Medical, INC. | $26.13 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Vanda Pharmaceuticals INC. | $22.50 | 2022 | |
| Inspire Medical Systems, INC. | $21.24 | 2023 | Inspire |
| Gilead Sciences, INC. | $18.84 | 2020 | |
| Jazz Pharmaceuticals INC. | $18.62 | 2021 | |
| Harmony Biosciences LLC | $17.96 | 2020 | |
| Eisai INC. | $17.76 | 2021 | |
| Electromed, INC. | $17.31 | 2019 | |
| Paratek Pharmaceuticals, INC. | $12.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Lipsett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.